Presented By: Stephen Little, PhD
Speaker Biography: Dr. Stephen Little is a British scientist and entrepreneur with a long and successful career in the fields of personalised medicine and molecular diagnostics. Following time spent as a research leader with Celltech and later AstraZeneca PLC he founded the pioneering personalised health company DxS and, following its sale to QIAGEN, went on to establish Premaitha Health (now Yourgene) as a leader in the field of reproductive genetics. He retains an active role at Yourgene but is also enthusiastically involved in the encouragement of exciting and interesting early stage companies such as Dxcover, Bioxhale and BioCaptiva.
Webinar: Keynote Presentation: Companion Diagnostics: Technical, Clinical and Commercial Challenges with Live Q&A
Webinar Abstract: The defining characteristic of Companion Diagnostics (CDx) is that their use is associated with selection of a therapy or other medical intervention. This combination of test and treatment creates complications as both parts of any new regime need to be coordinated. At the same time there are great opportunities to improve healthcare outcomes when personalised medicine is implemented effectively. This talk will take a high-level view of healthcare systems and suggest strategies to ensure successful translation of a CDx into clinical practice.
Earn PACE Credits:
1. Make sure you’re a registered member of Labroots ([ Ссылка ])
2. Watch the webinar on YouTube or on the Labroots Website ([ Ссылка ])
3. Click Here to get your PACE credits (Expiration date – May 17, 2025): ([ Ссылка ])
Labroots on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Pinterest: [ Ссылка ]
SnapChat: labroots_inc
